PL375960A1 - Zastosowanie soli distrontowej kwasu 2-[N,N-di(karboksymetylo)amino]-3-cyjano-4-karboksymetylo-tiofeno-5-karboksylowego do wytwarzania leku przeznaczonego do leczenia bólów żołądka i dwunastnicy - Google Patents

Zastosowanie soli distrontowej kwasu 2-[N,N-di(karboksymetylo)amino]-3-cyjano-4-karboksymetylo-tiofeno-5-karboksylowego do wytwarzania leku przeznaczonego do leczenia bólów żołądka i dwunastnicy

Info

Publication number: PL375960A1
Authority: PL; Poland
Prior art keywords: carboxymethyl; gastro; carboxylate; cyano; amino
Prior art date: 2002-11-05

Application number

PL03375960A

Other languages

English (en)

Other versions

PL214704B1 (pl

Inventor

Yannis Tsouderos

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-05

Filing date

2003-11-04

Publication date

2005-12-12

2003-11-04 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2005-12-12 Publication of PL375960A1 publication Critical patent/PL375960A1/pl

2013-09-30 Publication of PL214704B1 publication Critical patent/PL214704B1/pl

Links

239000003814 drug Substances 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
ZHEZAQJNZMLYBA-UHFFFAOYSA-J distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate;octahydrate Chemical compound O.O.O.O.O.O.O.O.[Sr+2].[Sr+2].[O-]C(=O)CN(CC([O-])=O)C=1SC(C([O-])=O)=C(CC([O-])=O)C=1C#N ZHEZAQJNZMLYBA-UHFFFAOYSA-J 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
229940079488 strontium ranelate Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL375960A 2002-11-05 2003-11-04 Zastosowanie soli distrontowej kwasu 2-[N,N-di(karboksymetylo)amino]-3-cyjano-4-karboksymetylo-tiofeno-5-karboksylowego do wytwarzania leku przeznaczonego do leczenia bólów zoladka i dwunastnicy PL214704B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0213805A FR2846558B1 (fr)	2002-11-05	2002-11-05	Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales

Publications (2)

Publication Number	Publication Date
PL375960A1 true PL375960A1 (pl)	2005-12-12
PL214704B1 PL214704B1 (pl)	2013-09-30

Family

ID=32104443

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL375960A PL214704B1 (pl)	2002-11-05	2003-11-04	Zastosowanie soli distrontowej kwasu 2-[N,N-di(karboksymetylo)amino]-3-cyjano-4-karboksymetylo-tiofeno-5-karboksylowego do wytwarzania leku przeznaczonego do leczenia bólów zoladka i dwunastnicy

Country Status (25)

Country	Link
US (1)	US7544710B2 (pl)
EP (1)	EP1560578B1 (pl)
JP (1)	JP4335146B2 (pl)
KR (1)	KR100735348B1 (pl)
CN (1)	CN1705479B (pl)
AT (1)	ATE328591T1 (pl)
AU (1)	AU2003292325B2 (pl)
BR (1)	BR0315917A (pl)
CA (1)	CA2503975C (pl)
CY (1)	CY1105105T1 (pl)
DE (1)	DE60305962T2 (pl)
DK (1)	DK1560578T3 (pl)
EA (1)	EA007863B1 (pl)
ES (1)	ES2264010T3 (pl)
FR (1)	FR2846558B1 (pl)
GE (1)	GEP20084463B (pl)
MA (1)	MA27406A1 (pl)
MX (1)	MXPA05004792A (pl)
NO (1)	NO333599B1 (pl)
NZ (1)	NZ539516A (pl)
PL (1)	PL214704B1 (pl)
PT (1)	PT1560578E (pl)
UA (1)	UA78618C2 (pl)
WO (1)	WO2004043455A1 (pl)
ZA (1)	ZA200503082B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2275218T3 (es)	2003-05-07	2007-06-01	Osteologix A/S	Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
WO2005123098A2 (en) *	2004-06-17	2005-12-29	Osteologix A/S	Preventing gastrointestinal side-effects with strontium salts
US20070292529A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating arthritic and or osteoporitic conditions
EP2530068A1 (en)	2011-05-31	2012-12-05	Lacer, S.A.	New strontium salts, synthesis and use thereof in the treatment of osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2651497B1 (fr) *	1989-09-01	1991-10-25	Adir	Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2740341B1 (fr) *	1995-10-26	1997-12-19	Oreal	Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2749759B1 (fr) *	1996-06-17	1999-11-26	Adir	Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2768621B1 (fr) *	1997-09-22	2000-04-07	Oreal	Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6489356B2 (en) *	2000-09-05	2002-12-03	Edward Leung	Method for treating pain in humans

2002
- 2002-11-05 FR FR0213805A patent/FR2846558B1/fr not_active Expired - Fee Related
2003
- 2003-04-11 UA UAA200505314A patent/UA78618C2/uk unknown
- 2003-11-04 NZ NZ539516A patent/NZ539516A/en not_active IP Right Cessation
- 2003-11-04 CA CA2503975A patent/CA2503975C/fr not_active Expired - Fee Related
- 2003-11-04 EA EA200500687A patent/EA007863B1/ru not_active IP Right Cessation
- 2003-11-04 US US10/533,787 patent/US7544710B2/en not_active Expired - Fee Related
- 2003-11-04 BR BR0315917-5A patent/BR0315917A/pt not_active IP Right Cessation
- 2003-11-04 PT PT03767891T patent/PT1560578E/pt unknown
- 2003-11-04 WO PCT/FR2003/003279 patent/WO2004043455A1/fr not_active Ceased
- 2003-11-04 PL PL375960A patent/PL214704B1/pl unknown
- 2003-11-04 AT AT03767891T patent/ATE328591T1/de active
- 2003-11-04 ES ES03767891T patent/ES2264010T3/es not_active Expired - Lifetime
- 2003-11-04 DE DE60305962T patent/DE60305962T2/de not_active Expired - Lifetime
- 2003-11-04 EP EP03767891A patent/EP1560578B1/fr not_active Expired - Lifetime
- 2003-11-04 CN CN2003801018229A patent/CN1705479B/zh not_active Expired - Fee Related
- 2003-11-04 GE GEAP20038823A patent/GEP20084463B/en unknown
- 2003-11-04 DK DK03767891T patent/DK1560578T3/da active
- 2003-11-04 JP JP2004550731A patent/JP4335146B2/ja not_active Expired - Fee Related
- 2003-11-04 KR KR1020057007989A patent/KR100735348B1/ko not_active Expired - Fee Related
- 2003-11-04 AU AU2003292325A patent/AU2003292325B2/en not_active Ceased
- 2003-11-04 MX MXPA05004792A patent/MXPA05004792A/es active IP Right Grant
2005
- 2005-04-14 MA MA28220A patent/MA27406A1/fr unknown
- 2005-04-15 ZA ZA200503082A patent/ZA200503082B/en unknown
- 2005-05-26 NO NO20052562A patent/NO333599B1/no not_active IP Right Cessation
2006
- 2006-07-24 CY CY20061101026T patent/CY1105105T1/el unknown

Also Published As

Publication number	Publication date
MXPA05004792A (es)	2005-07-22
DE60305962D1 (de)	2006-07-20
WO2004043455A1 (fr)	2004-05-27
MA27406A1 (fr)	2005-06-01
FR2846558A1 (fr)	2004-05-07
CN1705479B (zh)	2010-04-28
JP2006508112A (ja)	2006-03-09
HK1084029A1 (en)	2006-07-21
US7544710B2 (en)	2009-06-09
DE60305962T2 (de)	2007-02-08
NO20052562L (no)	2005-05-26
ZA200503082B (en)	2006-07-26
CA2503975A1 (fr)	2004-05-27
CA2503975C (fr)	2010-05-25
BR0315917A (pt)	2005-09-20
CY1105105T1 (el)	2009-11-04
AU2003292325A1 (en)	2004-06-03
US20060014824A1 (en)	2006-01-19
EP1560578A1 (fr)	2005-08-10
EA007863B1 (ru)	2007-02-27
KR100735348B1 (ko)	2007-07-04
NZ539516A (en)	2007-11-30
PL214704B1 (pl)	2013-09-30
JP4335146B2 (ja)	2009-09-30
AU2003292325B2 (en)	2008-07-31
KR20050072476A (ko)	2005-07-11
EP1560578B1 (fr)	2006-06-07
UA78618C2 (uk)	2007-04-10
ATE328591T1 (de)	2006-06-15
CN1705479A (zh)	2005-12-07
PT1560578E (pt)	2006-09-29
EA200500687A1 (ru)	2005-10-27
FR2846558B1 (fr)	2006-07-14
DK1560578T3 (da)	2006-10-02
NO333599B1 (no)	2013-07-22
ES2264010T3 (es)	2006-12-16
GEP20084463B (en)	2008-08-25

Similar Documents

Publication	Publication Date	Title
IL165264A (en)	2011-07-31	Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
TW200505881A (en)	2005-02-16	Tri(cyclo) substituted amide compounds
IS7814A (is)	2005-04-20	Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
IL164003A (en)	2011-12-29	Sulfonylamino-derivatives, compositions thereof, process of preparation and uses for the manufacture of medicaments for inhibiting histone deacetylase
WO2004021968A3 (en)	2004-05-27	Solution for ungual application
MXPA05004697A (es)	2005-10-18	Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades.
CY1110130T1 (el)	2015-01-14	Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
FR2848428B1 (fr)	2006-11-10	Composition cosmetique et procede pour le traitement des matieres keratiniques, comprenant un compose photodimerisable
IL166833A (en)	2010-12-30	2-arylthiazole compounds, process for their preparation and use thereof in the preparation of medicaments for the treatment of diseases modulated by pparalpha and ppargamma agonists
EP1422240A3 (en)	2005-01-05	Analogs of nociceptin
WO2003009898A8 (en)	2003-03-20	Treatment of hair follicle with neurokinin 1 receptor antagonists
PL375960A1 (pl)	2005-12-12	Zastosowanie soli distrontowej kwasu 2-[N,N-di(karboksymetylo)amino]-3-cyjano-4-karboksymetylo-tiofeno-5-karboksylowego do wytwarzania leku przeznaczonego do leczenia bólów żołądka i dwunastnicy
IL167250A (en)	2010-12-30	Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
PL1697005T3 (pl)	2012-02-29	Kombinacja flupirtyny i tramadolu
HUP0401773A3 (en)	2005-06-28	Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
AU2003258630A1 (en)	2004-03-11	Pyrimidine derivatives as selective cox-2 inhibitors
PL375629A1 (pl)	2005-12-12	Związki 1-fenylo-2-dimetyloaminometylocykloheksanu do terapii objawów depresyjnych, bólu i nietrzymania
MXPA05006408A (es)	2006-03-08	Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
SI1560578T1 (sl)	2006-08-31	Uporaba distroncijeve soli 2-(n,n-di(karboksimetil)amino)-3-ciano-4- karboksimetiltiofen-5-karboksilne kisline za pripravo zdravil za zdravljenje gastro-duodenalnih bolecin
AU2003246840A8 (en)	2003-11-03	Anti-hiv composition, production method thereof and medicament
PT1572686E (pt)	2009-07-14	Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
NO20045437L (no)	2004-12-13	Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
PT1474415E (pt)	2011-10-13	Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas
PL377524A1 (pl)	2006-02-06	Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych
PL370839A1 (pl)	2005-05-30	Zastosowanie inhibitorów pompy protonowej do leczenia zaburzeń dróg oddechowych